YU42172B - Process for obtaining new derivatives of 4-amino-5-alkyl-sulphonyl-orthdanizamide - Google Patents

Process for obtaining new derivatives of 4-amino-5-alkyl-sulphonyl-orthdanizamide

Info

Publication number
YU42172B
YU42172B YU50/79A YU5079A YU42172B YU 42172 B YU42172 B YU 42172B YU 50/79 A YU50/79 A YU 50/79A YU 5079 A YU5079 A YU 5079A YU 42172 B YU42172 B YU 42172B
Authority
YU
Yugoslavia
Prior art keywords
orthdanizamide
sulphonyl
amino
alkyl
obtaining new
Prior art date
Application number
YU50/79A
Other languages
English (en)
Other versions
YU5079A (en
Inventor
M Thoominet
J Acher
J C Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of YU5079A publication Critical patent/YU5079A/xx
Publication of YU42172B publication Critical patent/YU42172B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
YU50/79A 1978-01-20 1979-01-11 Process for obtaining new derivatives of 4-amino-5-alkyl-sulphonyl-orthdanizamide YU42172B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (2)

Publication Number Publication Date
YU5079A YU5079A (en) 1983-06-30
YU42172B true YU42172B (en) 1988-06-30

Family

ID=9203689

Family Applications (2)

Application Number Title Priority Date Filing Date
YU50/79A YU42172B (en) 1978-01-20 1979-01-11 Process for obtaining new derivatives of 4-amino-5-alkyl-sulphonyl-orthdanizamide
YU254/83A YU41278B (en) 1978-01-20 1983-02-04 Process for obtaining new derivatives of 4-amino-5-alkyl-sulfonyl-orthoanisamide

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU254/83A YU41278B (en) 1978-01-20 1983-02-04 Process for obtaining new derivatives of 4-amino-5-alkyl-sulfonyl-orthoanisamide

Country Status (42)

Country Link
US (2) US4294828A (nl)
JP (1) JPS6049192B2 (nl)
AR (2) AR221354A1 (nl)
AT (1) AT377977B (nl)
AU (1) AU528561B2 (nl)
BE (1) BE872585A (nl)
BG (2) BG31496A3 (nl)
CA (1) CA1101430A (nl)
CH (1) CH637927A5 (nl)
CS (1) CS226181B2 (nl)
CY (1) CY1201A (nl)
DD (1) DD141520A5 (nl)
DE (1) DE2901181C2 (nl)
DK (1) DK158346C (nl)
EG (1) EG14045A (nl)
ES (2) ES476755A1 (nl)
FI (1) FI71126C (nl)
FR (1) FR2415099A1 (nl)
GB (2) GB2012765B (nl)
GR (1) GR64431B (nl)
HK (1) HK12184A (nl)
HU (1) HU179793B (nl)
IE (1) IE47798B1 (nl)
IL (1) IL56411A (nl)
IN (1) IN150226B (nl)
IT (1) IT1164655B (nl)
LU (1) LU80786A1 (nl)
MC (1) MC1232A1 (nl)
MX (2) MX5793E (nl)
NL (1) NL191707C (nl)
NO (1) NO151320C (nl)
NZ (1) NZ189378A (nl)
OA (1) OA06156A (nl)
PH (2) PH15725A (nl)
PL (2) PL116532B1 (nl)
PT (1) PT69068A (nl)
RO (2) RO76393A (nl)
SE (2) SE448874B (nl)
SU (1) SU820659A3 (nl)
YU (2) YU42172B (nl)
ZA (1) ZA79219B (nl)
ZM (1) ZM579A1 (nl)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
ZA818221B (en) * 1980-12-12 1982-10-27 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
BRPI0410271A (pt) * 2003-05-16 2006-05-16 Pfizer Prod Inc combinações terapêuticas de antipsicóticos atìpicos com moduladores de gaba, anticonvulsivantes ou benzodiazepinas
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
BRPI0510942A (pt) * 2004-05-11 2007-07-17 Pfizer Prod Inc combinação de antipsicóticos atìpicos e antagonistas do receptor 5-ht1b
EP1879569A2 (en) * 2005-04-22 2008-01-23 Wyeth Therapeutic combinations for the treatment or prevention of psychotic disorders
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
JP2011526881A (ja) * 2008-06-25 2011-10-20 ファイザー・インク ジアリール化合物およびそれらの使用
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
GB201004020D0 (en) 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
EP2582665A1 (en) 2010-06-17 2013-04-24 Lupin Limited An improved process for preparation of amisulpride
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
CN111233731B (zh) * 2016-11-28 2021-05-14 Lb制药公司 精神药剂及其用途
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
CN112236138B (zh) 2017-12-05 2024-05-31 赛诺维信制药公司 晶体形式及其制备方法
CA3084953A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
SG11202113266YA (en) 2019-06-04 2021-12-30 Sunovion Pharmaceuticals Inc Modified release formulations and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (nl) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (fr) * 1975-02-07 1978-07-21 Ile De France Nouveau
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
DE2556457C3 (de) * 1974-12-18 1981-02-12 Synthelabo S.A., Paris N-(Pyrrolidin-2-yl-methyl)-2-methoxybenzamide, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
NL7900457A (nl) 1979-07-24
PT69068A (fr) 1979-02-01
ES477782A1 (es) 1979-09-16
YU41278B (en) 1986-12-31
ZM579A1 (en) 1979-12-21
CA1101430A (en) 1981-05-19
AT377977B (de) 1985-05-28
FR2415099B1 (nl) 1981-02-20
GB2083458B (en) 1983-03-09
FR2415099A1 (fr) 1979-08-17
PL118151B1 (en) 1981-09-30
NO790180L (no) 1979-07-23
NO151320B (no) 1984-12-10
OA06156A (fr) 1981-06-30
DK158346C (da) 1990-10-08
GB2012765A (en) 1979-08-01
DK20979A (da) 1979-07-21
CS226181B2 (en) 1984-03-19
PH15725A (en) 1983-03-18
US4294828A (en) 1981-10-13
NO151320C (no) 1985-04-17
ATA39879A (de) 1983-12-15
SE8603773D0 (sv) 1986-09-09
HK12184A (en) 1984-02-24
RO76393A (ro) 1981-03-30
MX5793E (es) 1984-07-19
IE790092L (en) 1979-07-20
SE460968B (sv) 1989-12-11
SE448874B (sv) 1987-03-23
ZA79219B (en) 1980-01-30
RO80311A (ro) 1982-12-06
YU5079A (en) 1983-06-30
SE7900380L (sv) 1979-07-21
NZ189378A (en) 1983-03-15
YU25483A (en) 1983-10-31
GB2083458A (en) 1982-03-24
GB2012765B (en) 1982-09-08
AR221354A1 (es) 1981-01-30
SU820659A3 (ru) 1981-04-07
IL56411A0 (en) 1979-03-12
FI790182A (fi) 1979-07-21
IN150226B (nl) 1982-08-21
FI71126B (fi) 1986-08-14
EG14045A (en) 1983-09-30
IL56411A (en) 1982-09-30
FI71126C (fi) 1986-11-24
MC1232A1 (fr) 1979-10-26
DK158346B (da) 1990-05-07
CY1201A (en) 1983-12-31
BE872585A (fr) 1979-06-07
NL191707C (nl) 1996-04-02
BG31497A3 (en) 1982-01-15
PH22287A (en) 1988-07-22
GR64431B (en) 1980-03-21
CH637927A5 (fr) 1983-08-31
JPS54145658A (en) 1979-11-14
JPS6049192B2 (ja) 1985-10-31
AU528561B2 (en) 1983-05-05
SE8603773L (sv) 1986-09-09
PL212899A1 (nl) 1980-01-14
LU80786A1 (fr) 1979-09-07
DE2901181C2 (de) 1984-07-19
HU179793B (en) 1982-12-28
PL116532B1 (en) 1981-06-30
NL191707B (nl) 1995-12-01
BG31496A3 (en) 1982-01-15
DE2901181A1 (de) 1979-07-26
DD141520A5 (de) 1980-05-07
MX7623E (es) 1990-03-27
US4401822A (en) 1983-08-30
ES476755A1 (es) 1979-06-01
AU4337379A (en) 1979-07-26
IT1164655B (it) 1987-04-15
IE47798B1 (en) 1984-06-27
AR220574A1 (es) 1980-11-14
IT7947706A0 (it) 1979-01-18

Similar Documents

Publication Publication Date Title
YU25483A (en) Process for obtaining new derivatives of 4-amino-5-alkyl-sulfonyl-orthoanisamide
YU42655B (en) Process for obtaining derivatives of carboxialkyldipeptides
YU67183A (en) Process for obtaining new derivatives of 6-beta-hydroxyalkyl penicillinates
RO83052B (ro) Procedeu pentru prepararea unor derivati de fenetanolamina
PT69202A (en) Process for preparing of 9-amino-dibenzopyrans
YU100379A (en) Process for obtaining new heterocyclic derivatives
HU186344B (en) Process for prodiction of solid cianur-chlorid
BG32115A4 (en) Method for obtaining of midantion
BG31493A3 (en) Method for obtaining of phenetanolamines
YU136880A (en) Process for obtaining new derivatives of 3-vinyl-cephalosporin
YU84179A (en) Process for obtaining 2-aminopyridone derivatives
YU80179A (en) Process for obtaining lysergol derivatives
YU42653B (en) Process for obtaining n-benzylhaloacetamide derivatives
YU187879A (en) Process for obtaining derivatives of phenyliminomethyl pyridine
HU178397B (en) Process for preparing substituted derivatives of steroid-spiro-oxazolidione derivatives
BG43187A3 (en) Method for preparing of auronic derivatives
YU43123B (en) Process for obtaining substituted derivatives of acylcarbamides
YU41184B (en) Process for obtaining 2-amino-or 2-thio-substituted derivatives of 4,5 dipheryl - oxazole
YU312378A (en) Process for obtaining 4-deoxy-4-arylglyoxamido-and aroylthioformamido derivatives of oleandomycin
EG13413A (en) Process for preparing of benzodiazeptine derivatives
YU20879A (en) Process for obtaining prostaglanid derivatives
YU147879A (en) Process for obtaining new heterocyclic derivatives
BG33285A3 (en) Method for obtaining of benzocyclopheptapyran
BG31228A3 (en) Method for obtaining of 2- metil- 2- xjdroxjpropjl piperazine- 1- carboxjate derivatives
EG13225A (en) Process for preparing of carbazales